102 related articles for article (PubMed ID: 25168905)
1. Integrated CT-perfusion shows no meaningful correlation with PSA and presurgical Gleason score in patients with early prostate cancer.
Huellner MW; Mattei A; Ross S; Butea-Bocu M; Vosbeck J; Pauli C; Diebold J; Seifert B; Strobel K; Veit-Haibach P
Clin Imaging; 2014; 38(6):850-7. PubMed ID: 25168905
[TBL] [Abstract][Full Text] [Related]
2. Assessment of prostate cancer with dynamic contrast-enhanced computed tomography using an en bloc approach.
Huellner MW; Pauli C; Mattei A; Ross S; Diebold J; Vosbeck J; Allgayer B; Strobel K; Veit-Haibach P
Invest Radiol; 2014 Sep; 49(9):571-8. PubMed ID: 24710202
[TBL] [Abstract][Full Text] [Related]
3. Correlation between CT perfusion and clinico-pathological features in prostate cancer: a prospective study.
Łuczyńska E; Heinze-Paluchowska S; Blecharz P; Jereczek-Fossa B; Petralia G; Bellomi M; Stelmach A
Med Sci Monit; 2015 Jan; 21():153-62. PubMed ID: 25582437
[TBL] [Abstract][Full Text] [Related]
4. Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter?
Jin BS; Kang SH; Kim DY; Oh HG; Kim CI; Moon GH; Kwon TG; Park JS
Korean J Urol; 2015 Sep; 56(9):624-9. PubMed ID: 26366274
[TBL] [Abstract][Full Text] [Related]
5. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].
Wetter A; Ajdukovic AN; Fliessbach K; Lehnert T; Engl T; Jacobi V; Vogl TJ
Rofo; 2006 Apr; 178(4):385-90. PubMed ID: 16607587
[TBL] [Abstract][Full Text] [Related]
6. CT-guided transgluteal biopsy for systematic sampling of the prostate in patients without rectal access: a 13-year single-center experience.
Olson MC; Atwell TD; Mynderse LA; King BF; Welch T; Goenka AH
Eur Radiol; 2017 Aug; 27(8):3326-3332. PubMed ID: 27975149
[TBL] [Abstract][Full Text] [Related]
7. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
[TBL] [Abstract][Full Text] [Related]
8. Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study.
Pereira RA; Costa RS; Muglia VF; Silva FF; Lajes JS; Dos Reis RB; Silva GE
Asian J Androl; 2015; 17(5):815-20. PubMed ID: 25652629
[TBL] [Abstract][Full Text] [Related]
9. Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB.
Bittner N; Merrick GS; Andreini H; Taubenslag W; Allen ZA; Butler WM; Anderson RL; Adamovich E; Wallner KE
Urology; 2009 Jul; 74(1):171-6. PubMed ID: 19232691
[TBL] [Abstract][Full Text] [Related]
10. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer.
Spencer JA; Chng WJ; Hudson E; Boon AP; Whelan P
Br J Radiol; 1998 Nov; 71(851):1130-5. PubMed ID: 10434906
[TBL] [Abstract][Full Text] [Related]
11. Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL.
Lee DH; Nam JK; Park SW; Lee SS; Han JY; Lee SD; Lee JW; Chung MK
Yonsei Med J; 2016 May; 57(3):565-71. PubMed ID: 26996553
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathologic characteristics and prognosis of early onset prostate cancer].
Wang Y; Du SJ; Zhang JX; He HY
Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):373-377. PubMed ID: 28591982
[No Abstract] [Full Text] [Related]
13. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
[TBL] [Abstract][Full Text] [Related]
14. Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative.
Faiella E; Santucci D; Greco F; Frauenfelder G; Giacobbe V; Muto G; Zobel BB; Grasso RF
Radiol Med; 2018 Feb; 123(2):143-152. PubMed ID: 29019021
[TBL] [Abstract][Full Text] [Related]
15. [Total PSA, PSA density and biopsy Gleason score in predicting the pathologic stage of prostate cancer].
Liu S; Lü JJ; Fu Q; Zhang H; Gao DX; Liu Z
Zhonghua Nan Ke Xue; 2010 May; 16(5):415-9. PubMed ID: 20684321
[TBL] [Abstract][Full Text] [Related]
16. Exploratory Radiomics in Computed Tomography Perfusion of Prostate Cancer.
Tanadini-Lang S; Bogowicz M; Veit-Haibach P; Huellner M; Pauli C; Shukla V; Guckenberger M; Riesterer O
Anticancer Res; 2018 Feb; 38(2):685-690. PubMed ID: 29374691
[TBL] [Abstract][Full Text] [Related]
17. High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL.
Miyoshi Y; Uemura H; Suzuki K; Shibata Y; Honma S; Harada M; Kubota Y
Andrology; 2017 Mar; 5(2):262-267. PubMed ID: 27813361
[TBL] [Abstract][Full Text] [Related]
18. Simple Risk Stratification to Detect Prostate Cancer with High Gleason Score in Repeat Biopsies in a Population Screening Follow-up Study.
Kitagawa Y; Urata S; Mizokami A; Nakashima K; Koshida K; Nakashima T; Miyazaki K; Namiki M
Anticancer Res; 2015 Sep; 35(9):5031-6. PubMed ID: 26254404
[TBL] [Abstract][Full Text] [Related]
19. Are predictive models for cancer volume clinically useful in localized prostate cancer?
Ishida M; Nakashima J; Hashiguchi A; Mizuno R; Shinoda K; Kikuchi E; Miyajima A; Nakagawa K; Mukai M; Oya M
Int J Urol; 2009 Dec; 16(12):936-40. PubMed ID: 19832923
[TBL] [Abstract][Full Text] [Related]
20. The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level.
Minamimoto R; Uemura H; Sano F; Terao H; Nagashima Y; Yamanaka S; Shizukuishi K; Tateishi U; Kubota Y; Inoue T
Ann Nucl Med; 2011 Jan; 25(1):21-7. PubMed ID: 20931305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
